<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The protective effect of vinpocetine on experimental <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> was studied in <z:hpo ids='HP_0001297'>stroke</z:hpo>-prone spontaneously hypertensive rats (SHRSP) with bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCAO) and in Wistar-Kyoto rats (WKY) subjected to BCAO and <z:mp ids='MP_0001914'>hemorrhage</z:mp> (1% of body weight) </plain></SENT>
<SENT sid="1" pm="."><plain>In SHRSP with BCAO, intraperitoneal (i.p.) injection of vinpocetine (1 mg/kg) 10 min before BCAO significantly prolonged the time required for the <z:hpo ids='HP_0003674'>onset</z:hpo> of ischemic <z:hpo ids='HP_0001250'>seizure</z:hpo> from 65 +/- 13 min (mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) to 117 +/- 19 min </plain></SENT>
<SENT sid="2" pm="."><plain>In WKY with BCAO and <z:mp ids='MP_0001914'>hemorrhage</z:mp>, vinpocetine (5 mg/kg, i.p.) reduced the <z:chebi fb="4" ids="24996">lactate</z:chebi> level in the cerebral cortex from 11.6 +/- 2.7 mmol/g to 5.9 +/- 1.2 mmol/g and elevated the concentration of ATP from 2.05 +/- 0.09 mmol/g to 2.25 +/- 0.03 mmol/g </plain></SENT>
<SENT sid="3" pm="."><plain>These results suggest a protective effect of vinpocetine against <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
</text></document>